Method of treating amyotrophic lateral sclerosis with dipeptide derivatives and pharmaceutical compositions for use therein
AssigneeGruenenthal GmbH
InventorsLeopold Flohe, Hans Barth
Life of this patent
Estimating the term…
Loading patent…
AssigneeGruenenthal GmbH
InventorsLeopold Flohe, Hans Barth
Estimating the term…
A method of treating patients suffering from amyotrophic lateral sclerosis (ALS) by administering dipeptide derivatives of the formula ##STR1## wherein R.sub.1 is hydrogen, a lower alkyl group, cyclohexyl or benzyl; Z is one of the groups ##STR2## wherein if Z is a group (a), R.sub.2 and R.sub.3 together represent an additional bond between the carbon atoms bearing R.sub.2 and R.sub.3, or if Z is a group (b), R.sub.2 is hydrogen; R.sub.4 and R.sub.5 are hydrogen or lower alkyl, or R.sub.5 may also be phenyl; and R.sub.6 is hydrogen or methyl; hydrates or pharmaceutically acceptable acid additions salts thereof. Pharmaceutical compositions containing effective ALS symptom counteracting amounts of such dipeptide derivatives may be administered by infusion, injection, orally, rectally or percutaneously.
A method of treating patients suffering from amyotrophic lateral sclerosis to obtain improvement in the clinical symptoms thereof comprising administering an effective amyotropic lateral sclerosis symptom counteracting amount of a dipeptide derivative corresponding to the formula ##STR6## wherein R.sub.1 represents a hydrogen atom, an alkyl group containing one to six carbon atoms, a cyclohexyl group or a benzyl group,
Dependencies are inferred from the claim text.